{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:37:03Z","timestamp":1793911023553,"version":"4.8.0"},"reference-count":18,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.24-0042","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:16:35Z","timestamp":1738275395000},"page":"n\/a","source":"Crossref","is-referenced-by-count":3,"title":["Intrahepatic Cholangiocarcinoma with <i>BRCA<\/i> Mutation Achieved Pathological Complete Response after Neoadjuvant Gemcitabine, Cisplatin, and S-1 Therapy: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-2487","authenticated-orcid":false,"given":"Yoshifumi","family":"Morita","sequence":"first","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"},{"name":"Division of Surgical Care, Morimachi, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kitajima","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"},{"name":"Department of Perioperative Functioning Care and Support, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ito","sequence":"additional","affiliation":[{"name":"Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Chida","sequence":"additional","affiliation":[{"name":"Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Noritake","sequence":"additional","affiliation":[{"name":"Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Kawata","sequence":"additional","affiliation":[{"name":"Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nagakura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kubo S, Shinkawa H, Asaoka Y, et al. Liver Cancer Study Group of Japan clinical practice guidelines for intrahepatic cholangiocarcinoma. Liver Cancer 2022; 11: 290\u2013314.","DOI":"10.1159\/000522403"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014; 149: 565\u201374.","DOI":"10.1001\/jamasurg.2013.5137"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. John Wiley & Sons, Hoboken, NJ, USA, 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Uenishi T, Ariizumi S, Aoki T, et al. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2014; 21: 499\u2013508.","DOI":"10.1002\/jhbp.92"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Weber SM, Ribero D, O\u2019Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17: 669\u201380.","DOI":"10.1111\/hpb.12441"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sha M, Cao J, Qin CL, et al. Impact of lymph node dissection for patients with clinically node-negative intrahepatic cholangiocarcinoma: a multicenter cohort study. World J Oncol 2024; 15: 579\u201391.","DOI":"10.14740\/wjon1895"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kang CM, Suh KS, Yi NJ, et al. Should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? A collaborative Korea-Japan study. Cancers (Basel) 2021; 13: 445.","DOI":"10.3390\/cancers13030445"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Umeda Y, Takagi K, Matsuda T, et al. Clinical implications and optimal extent of lymphadenectomy for intrahepatic cholangiocarcinoma: a multicenter analysis of the therapeutic index. Ann Gastroenterol Surg 2022; 7: 512\u201322.","DOI":"10.1002\/ags3.12642"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wehrle CJ, Chang J, Woo K, et al. Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up-front resection for resectable intrahepatic cholangiocarcinoma: a propensity-matched analysis. J Surg Oncol 2024; 130: 453\u201361.","DOI":"10.1002\/jso.27743"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci 2023; 30: 102\u201310.","DOI":"10.1002\/jhbp.1219"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matsubara T, Nishida T, Tomimaru Y, et al. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine\/cisplatin\/S-1 combination chemotherapy: a case report. Mol Clin Oncol 2016; 5: 757\u201361.","DOI":"10.3892\/mco.2016.1065"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tsunematsu M, Haruki K, Sakamoto T, et al. Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case. Surg Case Rep 2019; 5: 103.","DOI":"10.1186\/s40792-019-0656-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid 2022; 1: a2200015.","DOI":"10.1056\/EVIDoa2200015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401: 1853\u201365.","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nakamura H, Arai Y, Totoki Y, et al. Genomic spectra of biliary tract cancer. Nat Genet 2015; 47: 1003\u201310.","DOI":"10.1038\/ng.3375"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434: 917\u201321.","DOI":"10.1038\/nature03445"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet 2023; 401: 195\u2013203.","DOI":"10.1016\/S0140-6736(22)02038-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 2019; 20: 663\u201373.","DOI":"10.1016\/S1470-2045(18)30915-X"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0042\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:19:57Z","timestamp":1738387197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0042\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.24-0042","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.24-0042"}}